Can CYP Inhibition Overcome Chemotherapy Resistance?

anticancer drug resistance cytochrome P450 enzyme induction hepatocellular carcinoma

Journal

Trends in pharmacological sciences
ISSN: 1873-3735
Titre abrégé: Trends Pharmacol Sci
Pays: England
ID NLM: 7906158

Informations de publication

Date de publication:
08 2020
Historique:
received: 31 05 2020
accepted: 31 05 2020
pubmed: 24 6 2020
medline: 1 9 2021
entrez: 24 6 2020
Statut: ppublish

Résumé

A 2016 study proposed induction of the cytochrome P450 (CYP) enzyme CYP3A5 as a key mechanism for chemotherapy resistance and suggested CYP3A5 as a promising therapeutic target. However, in the context of the available literature we are skeptical that CYP3A5 contributes significantly to cancer drug resistance.

Identifiants

pubmed: 32571525
pii: S0165-6147(20)30136-X
doi: 10.1016/j.tips.2020.05.007
pii:
doi:

Substances chimiques

Cytochrome P-450 Enzyme System 9035-51-2

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-506

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Magnus Ingelman-Sundberg (M)

Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Volker M Lauschke (VM)

Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: volker.lauschke@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH